Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
Mie Reith MahlerMelinda MagyariLuigi PontieriFrederik ElberlingRolf Pringler HolmArkadiusz WeglewskiMai Bang PoulsenLars Kristian StorrPlamen Anzhelov BekyarovZsolt IllesMatthias KantTobias SejbaekMorten Leif StilundPeter V RasmussenMaria BraskInga UrbonaviciuteFinn SellebjergPublished in: Journal of neurology, neurosurgery, and psychiatry (2024)
A high number of pretreatment relapses was only associated with an increased risk of disease activity in females, while age had a differential impact on the risk of disease activity according to sex. Clinicians may consider age, sex and relapses when deciding on TFL treatment.